Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
RY ›
RYARZIL
Trademark search for:
RYARZIL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-09-17 — Application filed
2020-09-21 — Application filed
2020-10-27 — Application filed
2021-01-27 — Assigned to examiner
2021-02-03 — Priority action written
2021-02-03 — Priority action e-mailed
2021-02-03 — Notification of priority action e-mailed
2021-08-03 — Teas/email correspondence entered
2021-08-03 — Office action issued
2021-08-03 — Correspondence received in law office
2021-09-03 — Approved for pub - principal register
2021-09-22 — Notification of notice of publication e-mailed
2021-10-12 — Published for opposition
2021-10-12 — Official gazette publication confirmation e-mailed
2021-12-07 — Noa e-mailed - sou required from applicant
2022-06-06 — Attorney/dom.rep.revoked and/or appointed
2022-06-06 — Sou teas extension received
2022-06-06 — Teas change of correspondence received
2022-06-06 — Sou extension 1 filed
2022-06-06 — Sou extension 1 granted
2022-06-06 — Teas revoke/app/change addr of atty/dom rep received
2022-06-06 — Teas withdrawal of attorney received-firm retains
2022-06-08 — Notice of approval of extension request e-mailed
2022-12-07 — Sou teas extension received
2022-12-07 — Sou extension 2 filed
2022-12-07 — Sou extension 2 granted
2022-12-09 — Notice of approval of extension request e-mailed
2023-06-05 — Sou teas extension received
2023-06-05 — Sou extension 3 filed
2023-06-05 — Sou extension 3 granted
2023-06-06 — Assigned to examiner
2023-06-07 — Notice of approval of extension request e-mailed
2024-01-08 — Application abandoned
2024-01-08 — Application abandoned
2024-01-08 — Final status recorded
Owner Information
Eagle Pharmaceuticals Inc.
Eagle Pharmaceuticals Inc.
Correspondent
John M. Mueller BAKER & HOSTETLER LLP
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
